Background: Within the EU, some of the challenges and perceived risks now facing medical device (MD) developers result from changes in the regulatory framework, emphasizing safety. Therefore, medical technology companies must adopt stricter quality assurance measures so that individual devices can be speedily tracked and retrieved in emergency situations. Objectives: We highlight the challenges and risks faced by the European medical devices industry, particularly those faced by SMEs in the Czech Republic. We address two important research questions: Q1. Do advantages from increased regulation outweigh the additional expenses? Q2. As many MD developers are SMEs, will the new regulatory regime result in some of those companies going out of business and therefore impede future innovation? Methods: The paper focuses on a single case study, with the situation and outcomes discussed in the context of the financial results of a further 50 medical device manufacturers marketing in the Czech Republic. Results: Our findings suggest that the new legislation will result in improved safety, facilitate product recalls, but the cost and administrative burden may be high. The evidence also indicates that some SMEs may be forced to diversify to "non-medical" products, with the inevitable loss of innovative MDs being made available to patients and healthcare providers.

Department of Cybernetics and Biomedical Engineering Technical University of Ostrava Ostrava Czechia

Department of Economics University of Hradec Kralove Hradec Kralove Czechia

Zobrazit více v PubMed

MedTech Europe. From Diagnosis to Cure—Homepage. MedTech Europe (2019). Available online at: https://www.medtecheurope.org

Heneghan C, Thompson M, Billingsley M, Cohen D. Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts. BMJ Open. (2011) 1:e000155. 10.1136/bmjopen-2011-000155 PubMed DOI PMC

Council Directive 93/42/EEC of 14 June 1993 Concerning Medical Devices 31993L0042 CONSIL . OJ L 169 (1993). Available online at: http://data.europa.eu/eli/dir/1993/42/oj/eng

EUR-Lex-−32017R0745—EN - EUR-Lex . (2017). Available online at: https://eur-lex.europa.eu/legal-content/cs/ALL/?uri=CELEX%3A32017R0745 (accessed January 1, 2020).

Bergsland J, Elle OJ, Fosse E. Barriers to medical device innovation. Med Devices. (2014)7:205–9. 10.2147/MDER.S43369 PubMed DOI PMC

Leiter V, White SK. Enmeshed in controversy: claims about the risks of vaginal mesh devices. Health Risk Soc. (2015) 17:64–80. 10.1080/13698575.2014.1000835 DOI

White SK, Walters AN. Assessing risk by analogy: a case study of us medical device risk management policy. Health Risk Soc. (2018) 20:358–78.

de Mol BA. Regulation of risk management of medical devices and the role of litigation. J Risk Res. (2014) 17:735–48. 10.1080/13669877.2014.889201 PubMed DOI

Currie G, Humpreys M, Waring J, Rowley E. Narratives of professional regulation and patient safety: the case of medical devices in anaesthetics. Health Risk Soc. (2009) 11:117–35. 10.1080/13698570902784257 DOI

Porter M, Van der Linde C. Toward a new conception of the environment-competitiveness relationship. J Econ Perspect. (1995) 9:97–118.

Maresova P, Hajek L, Krejcar O, Storek M, Kuca K. New regulations on medical devices in Europe: are they an opportunity for growth? Admin Sci. (2020) 10:16. 10.3390/admsci10010016 DOI

ITA . United Kingdom—Medical Equipment (2019). Available online at: https://www.export.gov/apex/article2?id=United-Kingdom-Medical-Equipment (Retrieved June 15, 2020).

Panorama of the Manufacturing Industry of the Czech Republic (2017) . MPO. Available online at: https://www.mpo.cz/en/industry/manufacturing-industry/panorama-of-the-manufacturing-industry/panorama-of-the-manufacturing-industry-of-the-czech-republic-2017--240291/ (accessed December 27, 2019).

Minister Nováková: We Must Maintain and Develop the Production of Medical Devices in the Czech Republic | MPO . (2019). Available online at: https://www.mpo.cz/en/guidepost/for-the-media/press-releases/minister-novakova-we-must-maintain-and-develop-the-production-of-medical-devices-in-the-czech-republic–244664/ (accessed December 27, 2019).

Pane J, Coloma PM, Verhamme KMC, Sturkenboom MCJM, Rebollo I. Evaluating the safety profile of non-active implantable medical devices compared with medicines. Drug Saf. (2017) 40:37–47. 10.1007/s40264-016-0474-1 PubMed DOI PMC

Zippel C, Bohnet-Joschko S. Post market surveillance in the german medical device sector—Current state and future perspectives. Health Policy. (2017) 121:880–6. 10.1016/j.healthpol.2017.06.005 PubMed DOI

Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices Amending Directive 2001/83/EC Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and Repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA Relevance .), Vol. 117. Brussels: European Commission; (2017).

Brown A, Dixon D, Eatock J, Meenan BJ, Young T. A survey of success factors in New Product Development in the medical devices industry. In: IEEE International Engineering Management Conference. Estoril (2008). p. 1–5.

Fouretier A, Bertram D. New regulations on medical devices in Europe: what to expect? Expert Rev Med Devices. (2014) 11:351–9. 10.1586/17434440.2014.916209 PubMed DOI

Davey SM, Brennan M, Meenan BJ, McAdam R. Innovation in the medical device sector: an open business model approach for high-tech small firms. Technol Anal Strateg Manage. (2011) 23:807–24. 10.1080/09537325.2011.604152 DOI

Hourd PC, Williams DJ. Results from an exploratory study to identify the factors that contribute to success for UK medical device small- and medium-sized enterprises. Proc Inst Mech Eng H J Eng Med. (2008) 222:717–35. 10.1243/09544119JEIM125 PubMed DOI

Ghazilla RAR, Sakundarini N, Abdul-Rashid SH, Ayub NS, Olugu EU, Musa SN. Drivers and barriers analysis for green manufacturing practices in Malaysian SMEs: a preliminary findings. Proc CIRP. (2015) 26:658–63. 10.1016/j.procir.2015.02.085 DOI

Zhou Z-Y, Koerper MA, Johnson KA, Riske B, Baker JR, Ullman M, et al. . Burden of illness: direct and indirect costs among persons with hemophilia A in the United States. J Med Econ. (2015) 18:457–65. 10.3111/13696998.2015.1016228 PubMed DOI

Hasan MK, Sakib N, Love RR, Ahamed SI. RGB pixel analysis of fingertip video image captured from sickle cell patient with low and high level of hemoglobin. In: Chakrabarti S, Saha HN. editors. IEEE 8TH Annual Ubiquitous Computing, Electronics and Mobile Communication Conference (UEMCON) IEEE (2017). p. 499. Available online at: https://ieeexplore.ieee~org/abstract/document/8249004

Zhang S, Kriza C, Kolominsky-Rabas PL. (EMN on behalf of the National Leading-Edge Cluster Medical Technologies ‘Medical Valley). Assessing new developments in the pre-market regulatory process of medical devices in the People's Republic of China. Expert Rev Med Dev. (2014) 11:527–35. 10.1586/17434440.2014.932688 PubMed DOI

OECD . Measuring Regulatory Performance the Economic Impact of Regulatory Policy: a Literature Review of Quantitative Evidence (2012). Available online at: https://www.oecd.org/gov/regulatory-policy/3_Kirkpatrick%20Parker%20web.pdf (accessed March 10, 2021).

Peltzman S. An evaluation of consumer protection legislation: the 1962 drug amendments. J Polit Econ. (1973) 81:1049–91. 10.1086/260107 DOI

GEN . Does the FDA Regulatory Process Destroy Business Value? (2013). Available online at: https://www.genengnews.com/magazine/does-the-fda-regulatory-process-destroy-business-value/ (accessed March 10, 2021).

Patel M, Miller MA. Impact of regulatory science on global public health. Kaohsiung J Med Sci. (2012) 28:S5–9. 10.1016/j.kjms.2012.05.003 PubMed DOI PMC

Cardoen G. Overview. Public Health - European Commission. (2020). Available online at: https://ec.europa.eu/health/md_sector/overview_en

Medical Devices | BSI (2021) . Available online at: https://www.bsigroup.com/en-GB/medical-devices/ (accessed July 15, 2020).

Doe J. Medical Devices [Text]. Internal Market, Industry, Entrepreneurship and SMEs - European Commission. (2018). Available online at: https://ec.europa.eu/growth~/sectors/medical-devices_en

Regulation (EU) 2017/745 of the European Parliament of the Council of 5 April 2017 on Medical Devices Amending Directive 2001/83/EC Regulation (EC) No 178/2002 Regulation (EC) No 1223/2009 Repealing Council Directives 90/385/EEC 93/42/EEC (Text with EEA relevance.), Pub. L. No. 32017R0745, 117 OJ L. (2017). Available online at: http://data.europa.eu~/eli/reg/2017/745/oj/eng

Council Directive 93/42/EEC of 14 June 1993 Concerning Medical Devices 31993L0042 CONSIL OJ L 169. (1993). Available online at: http://data.europa.eu/eli/dir/1993/42/oj/eng

Dymacek M. MEDICAL TRIBUNE CZ > MDR poprvé – další tri písmena, která by vás měla děsit?. (2019). Available online at: https://www.tribune.cz/clanek/44517-mdr-poprve-dalsi-tri-pismena-ktera-by-vas-mela-desit (accessed December 27, 2019).

Institiute of Medicine (US) C . on in T. I. Gelijns AC, Halm EA. The dynamics of medical device innovation: an innovator's perspective. In: The Changing Economics of Medical Technology. Academies Press (US) (1991). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK234310/ PubMed

Bernasconi S. How MDR and IVDR Are Reshaping Europe's Medtech Industry (Pulse of the Industry (2017). pp. 28–29) [Medical Technology Report 2017]. EY - Ernst Young. Available online at: https://www.ey.com/Publication/vwLUAssets/ey-pulse-of-the-industry-2017/$FILE/ey-pulse-of-the-industry-2017.pdf

EUCOMED - Medical Technology . Financial Impact of the Revision of the EU Medical Devices Directives on European SMEs and Industry (New Medtech Regulations, p. 3) [Factsheet]. MedTechEurope (2013). Available online at: https://www.medtecheurope.org/wp-content/uploads~/2015/07/20130910_MTE_Financial-impact-of-the-Revision-of-the-EU-Medical-Devices-Directives-on-European-SMEs-and-industry_factsheet.pdf

Global Research and Data Services . Medical Device Market in Czech Republic to 2020 - Market Size, Development, and Forecasts. Report (2016).

Emergo . Czech Republic – Overview of Device Industry and Healthcare Statistics. (2017). Available online at: https://www.emergobyul.com/resources/market-czech-republic (accessed March 10, 2021).

Stake R. The Art of Case Study Research. SAGE Publications Ltd. (2020). Available online at: https://uk.sagepub.com/en-gb/eur/the-art-of-case-study-research/book4954

Lefley F. Can a project champion bias project selection and, if so, how can we avoid it? Manage Res News. (2006) 29:174–83. 10.1108/01409170610665031 DOI

Yin RK. Case Study Research: Design and Methods (2009). Thousand Oaks, CA: SAGE.

Rodriguez SG. Yin Case Study Research Design and Methods (Applied Social Research Methods). 4th Edn. Sage Publications Incorporated; (2008). Available online at: https://www.academia.edu/32420108/Yin_Case_Study_Research_Design_and_Methods (accessed June 15, 2020).

Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh A. The case study approach. BMC Med Res Methodol. (2011) 11:100. 10.1186/1471-2288-11-100 PubMed DOI PMC

Registr Zdravotnických Prostredku—RZPRO (Národní registr zdravotnických prostøedkù),. (2021). Available online at: https://eregpublicsecure.ksrzis.cz/ Registr/RZPRO/ (accessed July 15, 2020).

Asociace výrobcu a dodavatelu zdravotnickcýh prostredku/AVDZP . Available online at: https://avdzp.cz/ (accessed July 15, 2020).

Rešení pro B2B Marketing—Bisnode Ceská republika . Available online at: https://www.bisnode.cz/campaign/reseni-pro-b2b-marketing/ (accessed June 15, 2020).

IBM (2014 October 24) . Available online at: http://www.ibm.com/support/knowledgecenter/en/sslvmb_23.0.0/spss~%20/trends/idh_idd_tab_vars.html

Sommersguter-Reichmann M, Wild C, Stepan A, Reichmann G, Fried A. Individual and institutional corruption in European and US healthcare: overview and link of various corruption typologies. Appl Health Econ Health Policy. (2018) 16:289–302. 10.1007/s40258-018-0386-6 PubMed DOI PMC

Kramer DB, Tan YT, Sato C, Kesselheim AS. Ensuring medical device effectiveness and safety: a cross - national comparison of approaches to regulation. Food Drug Law J. (2014) 69:1–23, i. PubMed PMC

The European Research Centre for Anti-Corruption and State-Building (ERCAS) . Agains Corruption – Czech Republic. Available online at: https://www.againstcorruption.eu/countries/czech-republic/

Impact of Regulatory Changes on Innovations in the Medical Device Industry Comment on "Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? - A Viewpoint Paper"

Critical Factors and Economic Methods for Regulatory Impact Assessment in the Medical Device Industry